The cancer biomarker problem : Molecular cancer diagnosticsSAWYERS, Charles L.Nature (London). 2008, Vol 452, Num 7187, pp 548-552, issn 0028-0836, 5 p.Article

Will kinase inhibitors have a dark side?SAWYERS, Charles L.The New England journal of medicine. 2006, Vol 355, Num 3, pp 313-315, issn 0028-4793, 3 p.Article

Implications of Signal Transduction Inhibition for the Treatment of chronic Myeloid LeukemiaSAWYERS, Charles L.Seminars in hematology. 2001, Vol 38, Num 3, issn 0037-1963, 44 p., SUP8Serial Issue

Implications of imatinib mesylate for hematopoietic stem cell transplantationGOLDMAN, John.Seminars in hematology. 2001, Vol 38, Num 3, pp 28-34, issn 0037-1963, SUP8Article

Signal transduction inhibition: Results from phase I clinical trials in chronic myeloid leukemiaDRUKER, Brian.Seminars in hematology. 2001, Vol 38, Num 3, pp 9-14, issn 0037-1963, SUP8Article

The role of Bcr-Abl in chronic myeloid leukemia and stem cell biologyWITTE, Owen.Seminars in hematology. 2001, Vol 38, Num 3, pp 3-8, issn 0037-1963, SUP8Article

Interferon-alfa-based treatment of chronic myeloid leukemia and implications of signal transduction inhibitionTALPAZ, Moshe.Seminars in hematology. 2001, Vol 38, Num 3, pp 22-27, issn 0037-1963, SUP8Article

Cancer treatment in the STI571 era : What will change?SAWYERS, Charles L.Journal of clinical oncology. 2001, Vol 19, Num 18, pp 13s-16s, issn 0732-183X, SUPConference Paper

Setting up a Kinase Discovery and Development ProjectBOLLAG, Gideon.Current Topics in Microbiology and Immunology. 2012, Vol 355, pp 3-18, issn 0070-217X, 16 p.Article

Biology of progressive, castration-resistant prostate cancer : Directed therapies targeting the androgen-receptor signaling axisSCHER, Howard I; SAWYERS, Charles L.Journal of clinical oncology. 2005, Vol 23, Num 32, pp 8253-8261, issn 0732-183X, 9 p.Article

Perspectives on the future of chronic myeloid leukemia treatmentAPPELBAUM, Frederick R.Seminars in hematology. 2001, Vol 38, Num 3, pp 35-42, issn 0037-1963, SUP8Article

Therapeutic kinase inhibitorsMELLINGHOFF, Ingo K; SAWYERS, Charles L.Current Topics in Microbiology and Immunology. 2012, Vol 355, issn 0070-217X, 242 p.Serial Issue

Molecular studies in chronic myeloid leukemia patients treated with tyrosine kinase inhibitorsSAUYERS, Charles L.Seminars in hematology. 2001, Vol 38, Num 3, pp 15-21, issn 0037-1963, SUP8Article

Gastrointestinal Stromal TumorsANTONESCU, Cristina.Current Topics in Microbiology and Immunology. 2012, Vol 355, pp 41-57, issn 0070-217X, 17 p.Article

Molecular mechanisms of resistance to STI571 in chronic myeloid leukemiaGORRE, Mercedes E; SAWYERS, Charles L.Current opinion in hematology. 2002, Vol 9, Num 4, pp 303-307, issn 1065-6251Article

Growth inhibitory effects of the dual ErbB1/ErbB2 tyrosine kinase inhibitor PKI-166 on human prostate cancer xenograftsMELLINGHOFF, Ingo K; TRAN, Chris; SAWYERS, Charles L et al.Cancer research (Baltimore). 2002, Vol 62, Num 18, pp 5254-5259, issn 0008-5472, 6 p.Article

EGFR Mutant Lung CancerYIXUAN GONG; PAO, William.Current Topics in Microbiology and Immunology. 2012, Vol 355, pp 59-81, issn 0070-217X, 23 p.Article

Mechanisms of resistance to STI571 in Philadelphia chromosome-associated leukemiasSHAH, Neil P; SAWYERS, Charles L.Oncogene (Basingstoke). 2003, Vol 22, Num 47, pp 7389-7395, issn 0950-9232, 7 p.Article

JAK-Mutant Myeloproliferative NeoplasmsLEVINE, Ross L.Current Topics in Microbiology and Immunology. 2012, Vol 355, pp 119-133, issn 0070-217X, 15 p.Article

Adjuvant Trials of Targeted Agents: The Newest Battleground in the War on CancerCOHEN, Robert L.Current Topics in Microbiology and Immunology. 2012, Vol 355, pp 217-232, issn 0070-217X, 16 p.Article

Beyond BRAF in MelanomaDAUD, Adil; BASTIAN, Boris C.Current Topics in Microbiology and Immunology. 2012, Vol 355, pp 99-117, issn 0070-217X, 19 p.Article

BCR-ABL point mutants isolated from patients with imatinib mesylate-resistant chronic myeloid leukemia remain sensitive to inhibitors of the BCR-ABL chaperone heat shock protein 90GORRE, Mercedes E; ELLWOOD-YEN, Katharine; CHIOSIS, Gabriela et al.Blood. 2002, Vol 100, Num 8, pp 3041-3044, issn 0006-4971, 4 p.Article

Predictive Genomic BiomarkersKUMAR, Rakesh; AMADO, Rafael G.Current Topics in Microbiology and Immunology. 2012, Vol 355, pp 173-188, issn 0070-217X, 16 p.Article

MicroPET imaging of prostate cancer in LNCAP-SR39TK-GFP mouse xenograftsHONGHAO YANG; BERGER, Frank; TRAN, Chris et al.The Prostate. 2003, Vol 55, Num 1, pp 39-47, issn 0270-4137, 9 p.Article

TMEFF2 is an androgen-regulated gene exhibiting antiproliferative effects in prostate cancer cellsGERY, Sigal; SAWYERS, Charles L; AGUS, David B et al.Oncogene (Basingstoke). 2002, Vol 21, Num 31, pp 4739-4746, issn 0950-9232, 8 p.Article